Herpes Zoster Market is Expected to Expand a Promising Double-Digit CAGR of 12.7% During Forecast 2018-2023
Market Highlights: Herpes zoster (shingles) spreads from people suffering from chicken-pox. The mode of transmission is through metabolic process droplets, skin lesions, by direct contact or through aerosols. Currently, there are only two vaccines licensed and available in the US for shingles namely Zostavax (zoster vaccine live) and Shingrix (recombinant zoster vaccine). Both these vaccines are safe and effective and has potential side effects. Generally, the diagnosis of this condition is through laboratory testing. Additionally, the first line of treatment is through medication which include oral medicines (Antihistamines), topical (numbing creams, gels, or patches), and vaccines. Typically, the vaccines are administered to the geriatric population as they are at a higher risk to contract this disease. The herpes zoster market is expected to witness tremendous growth owing to rising incidence of herpes zoster coupled with rising geriatric population are factors contributing to...